Cahill Represents Initial Purchasers in $900 Million Notes Offering by Valeant
December 2, 2013
Cahill represented the joint book-running managers, senior co-managers and co-managers in connection with a Rule 144A/Reg S Offering of $900,000,000 aggregate principal amount of 5.625% Senior Notes due 2021 by Valeant Pharmaceuticals International, Inc. Proceeds from the offering were used to refinance existing indebtedness.
